The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIMEL

被引:28
作者
Guo, Y. [2 ]
Schoell, M. C. [1 ]
Freeman, R. S. [1 ]
机构
[1] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med, Interdept Grad Program Neurosci, Rochester, NY 14642 USA
基金
美国国家卫生研究院;
关键词
VHL; BIMEL; renal cell carcinoma; apoptosis; protein stability; TUMOR-SUPPRESSOR PROTEIN; PROLYL HYDROXYLASE; MOLECULAR-BASIS; GENE-PRODUCT; HIF-ALPHA; CANCER; PHOSPHORYLATION; EXPRESSION; COMPLEX; FAMILY;
D O I
10.1038/onc.2009.35
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
von Hippel-Lindau (VHL) disease is caused by germ-line mutations in the VHL tumor suppressor gene and is the most common cause of inherited renal cell carcinoma (RCC). Mutations in the VHL gene also occur in a large majority of sporadic cases of clear-cell RCC, which have high intrinsic resistance to chemotherapy and radiotherapy. Here we show that VHL-deficient RCC cells express lower levels of the proapoptotic Bcl-2 family protein BIMEL and are more resistant to etoposide and UV radiation-induced death compared to the same cells stably expressing the wild-type VHL protein (pVHL). Reintroducing pVHL into VHL-null cells increased the half-life of BIMEL protein without affecting its mRNA expression, and overexpressing pVHL inhibited BIMEL polyubiquitination. Suppressing pVHL expression with RNA interference resulted in a decrease in BIMEL protein and a corresponding decrease in the sensitivity of RCC cells to apoptotic stimuli. Directly inhibiting BIMEL expression in pVHL-expressing RCC cells caused a similar decrease in cell death. These results demonstrate that pVHL acts to promote BIMEL protein stability in RCC cells, and that destabilization of BIMEL in the absence of pVHL contributes to the increased resistance of VHL-null RCC cells to certain apoptotic stimuli.
引用
收藏
页码:1864 / 1874
页数:11
相关论文
共 42 条
  • [1] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
    Bouillet, P
    Metcalf, D
    Huang, DCS
    Tarlinton, DM
    Kay, TWH
    Köntgen, F
    Adams, JM
    Strasser, A
    [J]. SCIENCE, 1999, 286 (5445) : 1735 - 1738
  • [2] A conserved family of prolyl-4-hydroxylases that modify HIF
    Bruick, RK
    McKnight, SL
    [J]. SCIENCE, 2001, 294 (5545) : 1337 - 1340
  • [3] Advances in the molecular basis of renal neoplasia
    Cohen, HT
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (03) : 325 - 331
  • [4] The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways
    Devarajan, P
    De Leon, M
    Talasazan, F
    Schoenfeld, AR
    Davidowitz, EJ
    Burk, RD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) : 40599 - 40605
  • [5] C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
    Epstein, ACR
    Gleadle, JM
    McNeill, LA
    Hewitson, KS
    O'Rourke, J
    Mole, DR
    Mukherji, M
    Metzen, E
    Wilson, MI
    Dhanda, A
    Tian, YM
    Masson, N
    Hamilton, DL
    Jaakkola, P
    Barstead, R
    Hodgkin, J
    Maxwell, PH
    Pugh, CW
    Schofield, CJ
    Ratcliffe, PJ
    [J]. CELL, 2001, 107 (01) : 43 - 54
  • [6] Bim and the pro-survival bcl-2 proteins - Opposites attract, ERK repels
    Ewings, Katherine E.
    Wiggins, Ceri M.
    Cook, Simon J.
    [J]. CELL CYCLE, 2007, 6 (18) : 2236 - 2240
  • [7] pVHL: A Multipurpose Adaptor Protein
    Frew, Ian J.
    Krek, Wilhelm
    [J]. SCIENCE SIGNALING, 2008, 1 (24) : pe30
  • [8] EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability
    Fu, Jian
    Menzies, Keon
    Freeman, Robert S.
    Taubman, Mark B.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (17) : 12410 - 12418
  • [9] MUTATIONS OF THE VHL TUMOR-SUPPRESSOR GENE IN RENAL-CARCINOMA
    GNARRA, JR
    TORY, K
    WENG, Y
    SCHMIDT, L
    WEI, MH
    LI, H
    LATIF, F
    LIU, S
    CHEN, F
    DUH, FM
    LUBENSKY, I
    DUAN, DR
    FLORENCE, C
    POZZATTI, R
    WALTHER, MM
    BANDER, NH
    GROSSMAN, HB
    BRAUCH, H
    POMER, S
    BROOKS, JD
    ISAACS, WB
    LERMAN, MI
    ZBAR, B
    LINEHAN, WM
    [J]. NATURE GENETICS, 1994, 7 (01) : 85 - 90
  • [10] Gorospe M, 1999, MOL CELL BIOL, V19, P1289